MUMBAI, India, Feb. 21 -- Intellectual Property India has published a patent application (202321054553 A) filed by Anand Pharmacy College, Anand, Gujarat, on Aug. 14, 2023, for 'a nepafenac and dexamethasone nanomicelles laden in situ gel.'
Inventor(s) include Dr. Tejal R. Gandhi; Makwana Smit S.; Patel Mansi N.; Dr. Vaishali T. Thakkar; and Dr. Hardik B. Rana.
The application for the patent was published on Feb. 21, under issue no. 08/2025.
According to the abstract released by the Intellectual Property India: "The present invention is related to a nepafenac and dexamethasone nanomicelles laden in situ gel. The present invention particularly relates to in situ gel for controlled ocular delivery of nepafenac and dexamethasone comprising ...